Dr. Devi Nair, MD
Claim this profileArrhythmia Research Group
Expert in Atrial Fibrillation
Studies Stroke
21 reported clinical trials
28 drugs studied
About Devi Nair, MD
Education:
- Earned an MD from the University of Texas Southwestern Medical Center, Dallas, TX.
- Completed Residency in Internal Medicine at the University of California, San Francisco (UCSF).
- Undertook Fellowships in Cardiovascular Disease and Clinical Cardiac Electrophysiology at UCSF.
Experience:
- Specializes in cardiac electrophysiology with the Arrhythmia Research Group.
- Received comprehensive training at UCSF, a leading academic medical center.
Affiliated Hospitals
Clinical Trials Devi Nair, MD is currently running
WATCHMAN Device
for Atrial Fibrillation
LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
Recruiting1 award N/A3 criteria
Catheter Ablation + HF Therapies
for Heart Failure and Atrial Fibrillation
Heart failure (HF) with preserved left ventricular function (pEF) is difficult clinical syndrome to treat effectively with few evidence based therapies. Atrial fibrillation (AF) is now an important co-morbidity being observed in 43% of patients with HFpEF. Rhythm control has not been studied in this population. Catheter ablation and antiarrhythmic drugs are rhythm control therapies that have been used for treatment of AF without HF or HF with reduced systolic function but have not been widely applied in HFpEF. No controlled comparative evaluation has been performed in HFpEF. The introduction of wireless pulmonary artery hemodynamic monitoring has permitted optimization of HF therapy in patients with chronic HF with reduced and preserved EF. Reduction in HF hospitalizations has been observed in post hoc analyses of HFpEF patients but has not been systematically applied in AF patients with HFpEF. In this study, we propose to study both rhythm control and optimized HF therapeutic approaches in an AF with HFpEF study population in a pilot study using a sequential two phase randomized controlled clinical trial design.
Recruiting3 awards Phase 413 criteria
More about Devi Nair, MD
Clinical Trial Related1 year of experience running clinical trials · Led 21 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Devi Nair, MD has experience with
- Catheter Ablation
- Confirm Rx Insertable Cardiac Monitor
- Investigational LUX-Dx ICM Implant
- Renal Denervation
- TactiFlex SE
- TactiFlex SE - HSP
Breakdown of trials Devi Nair, MD has run
Atrial Fibrillation
Stroke
Cardiac Arrhythmias
Arrhythmia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Devi Nair, MD specialize in?
Devi Nair, MD focuses on Atrial Fibrillation and Stroke. In particular, much of their work with Atrial Fibrillation has involved Stage III patients, or patients who are undergoing treatment.
Is Devi Nair, MD currently recruiting for clinical trials?
Yes, Devi Nair, MD is currently recruiting for 4 clinical trials in Jonesboro Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Devi Nair, MD has studied deeply?
Yes, Devi Nair, MD has studied treatments such as Catheter Ablation, Confirm Rx Insertable Cardiac Monitor, Investigational LUX-Dx ICM Implant.
What is the best way to schedule an appointment with Devi Nair, MD?
Apply for one of the trials that Devi Nair, MD is conducting.
What is the office address of Devi Nair, MD?
The office of Devi Nair, MD is located at: Arrhythmia Research Group, Jonesboro, Arkansas 72401 United States. This is the address for their practice at the Arrhythmia Research Group.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.